Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC Trial)

Saved in:

Bibliographic Details
Main Authors:	Kröger, Nicolaus (Author) , Iacobelli, Simona (Author) , Franke, Georg-Nikolaus (Author) , Platzbecker, Uwe (Author) , Uddin, Ruzena (Author) , Hübel, Kai (Author) , Scheid, Christoph (Author) , Weber, Thomas (Author) , Robin, Marie (Author) , Stelljes, Matthias (Author) , Afanasyev, Boris (Author) , Heim, Dominik (Author) , Deliliers, Giorgio Lambertenghi (Author) , Onida, Francesco (Author) , Dreger, Peter (Author) , Pini, Massimo (Author) , Guidi, Stefano (Author) , Volin, Liisa (Author) , Günther, Andreas (Author) , Bethge, Wolfgang Andreas (Author) , Poiré, Xavier (Author) , Kobbe, Guido (Author) , Os, Marleen van (Author) , Brand, Ronald (Author) , Witte, Theo de (Author)
Format:	Article (Journal)
Language:	English
Published:	May 2, 2017
In:	Journal of clinical oncology Year: 2017, Volume: 35, Issue: 19, Pages: 2157-2164
ISSN:	1527-7755
DOI:	10.1200/JCO.2016.70.7349
Online Access:	Resolving-System, Volltext: https://doi.org/10.1200/JCO.2016.70.7349
Author Notes:	Nicolaus Kröger, Simona Iacobelli, Georg-Nikolaus Franke, Uwe Platzbecker, Ruzena Uddin, Kai Hübel, Christof Scheid, Thomas Weber, Marie Robin, Matthias Stelljes, Boris Afanasyev, Dominik Heim, Giorgio Lambertenghi Deliliers, Francesco Onida, Peter Dreger, Massimo Pini, Stefano Guidi, Liisa Volin, Andreas Günther, Wolfgang Bethge, Xavier Poiré, Guido Kobbe, Marleen van Os, Ronald Brand, Theo de Witte

Similar Items